Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M45.2Revenue (TTM) $M2.8Net Margin (%)-1,321.9Altman Z-Score-20.3
Enterprise Value $M33.3EPS (TTM) $-0.5Operating Margin %-1,418.9Piotroski F-Score2
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-1,321.9Higher ROA y-yN
Price/Book16.310-y EBITDA Growth Rate %-31.9Quick Ratio4.2Cash flow > EarningsN
Price/Sales14.15-y EBITDA Growth Rate %-5.0Current Ratio4.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-93.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-203.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M86.9ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with SNSS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNSSFirst Eagle Investment 2015-06-30 Sold Out $2.07 - $3.01
($2.53)
$ 0.52-79%Sold Out0
SNSSFirst Eagle Investment 2015-03-31 Reduce-0.01%$2.1 - $2.83
($2.4)
$ 0.52-78%Reduce -58.43%587,976
SNSSFirst Eagle Investment 2014-12-31 Buy 0.01%$1.05 - $6.64
($2.06)
$ 0.52-75%New holding1,414,276
SNSSFirst Eagle Investment 2014-09-30 Sold Out -0.0032%$5.55 - $8.23
($6.9)
$ 0.52-92%Sold Out0
SNSSFirst Eagle Investment 2013-09-30 Buy $4.55 - $6.05
($5.08)
$ 0.52-90%New holding200,000
SNSSFirst Eagle Investment 2013-03-31 Sold Out -0.0052%$4 - $6.49
($5.2)
$ 0.52-90%Sold Out0
SNSSFirst Eagle Investment 2012-09-30 Reduce$2.95 - $5.76
($3.55)
$ 0.52-85%Reduce -30.24%350,000
SNSSFirst Eagle Investment 2012-06-30 Buy 0.01%$2.51 - $3.18
($2.78)
$ 0.52-81%New holding501,727
SNSSFirst Eagle Investment 2012-03-31 Sold Out -0.0026%$1.17 - $2.87
($1.79)
$ 0.52-71%Sold Out0
SNSSFirst Eagle Investment 2009-12-31 Sold Out $1.8 - $12.54
($3.79)
$ 0.52-86%Sold Out0
SNSSFirst Eagle Investment 2009-06-30 Reduce$0.99 - $3.45
($1.95)
$ 0.52-73%Reduce -90.60%16,667
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNSS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


SNSS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Parker Geoffrey M.Director 2016-05-26Buy9,500$0.4710.64view
Parker Geoffrey M.Director 2016-05-25Buy52,505$0.4710.64view
Misfeldt DaytonDirector 2015-12-21Buy1,750,000$0.84-38.1view
Swisher Daniel N JRPresident and CEO 2015-08-25Buy25,000$1.01-48.51view
Ketchum Steven BDirector 2015-07-24Sell6,358$3.46-84.97view
BJERKHOLT ERICEVP, CFO & Corp. Secretary 2015-07-24Sell6,358$3.46-84.97view
Swisher Daniel N JRPresident and CEO 2015-07-24Sell12,715$3.46-84.97view
BAY CITY CAPITAL LLC10% Owner 2015-07-24Sell635,702$3.46-84.97view
Misfeldt DaytonDirector 2015-07-24Sell635,702$3.46-84.97view
BARRIS PETER J10% Owner 2014-08-29Sell266,700$7.97-93.48view

Quarterly/Annual Reports about SNSS:

News about SNSS:

Articles On GuruFocus.com
Roundys Among Largest Insiders' Buys of the Week Dec 31 2015 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 
Weekly CFO Buys Highlight: SNSS, INUV, CEP, CMTL, SURW Oct 09 2010 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 13 2010 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Apr 29 2010 
Hardest Hit Companies of the Day: Transition Therapeutics Inc., Sunesis Pharmaceuticals Inc., GenCor Dec 15 2009 
Most Trade Guru Stocks: Citigroup Inc., Bank of America Corp., Alcoa Inc., Sunesis Pharmaceuticals Dec 12 2009 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 16 2009 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Jul 28 2009 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) May 08 2009 

More From Other Websites
Sunesis Pharmaceuticals (SNSS) in Focus: Stock Gains 8.7% Jun 21 2016
7 Biotech Stocks that are Buys Right Now Jun 17 2016
Sunesis Pharmaceuticals Announces Presentation of Positive Results from MD Anderson Sponsored Trial... Jun 13 2016
Sunesis Pharmaceuticals Announces Presentation of Positive Results from MD Anderson Sponsored Trial... Jun 13 2016
Most Popular Healthcare Penny Stocks Among Hedge Funds Jun 09 2016
SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 08 2016
ETF’s with exposure to Sunesis Pharmaceuticals, Inc. : June 6, 2016 Jun 06 2016
Sunesis Announces Study Examining the Value of Complete Remission Prior to HCT in Patients with AML... Jun 06 2016
Sunesis Announces Study Examining the Value of Complete Remission Prior to HCT in Patients with AML... Jun 06 2016
Sunesis Pharmaceuticals Appoints Linda Neuman, M.D., as Vice President, Clinical Development Jun 01 2016
Sunesis Pharmaceuticals Appoints Linda Neuman, M.D., as Vice President, Clinical Development Jun 01 2016
SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... May 27 2016
Sunesis Pharmaceuticals Announces Support of First-Ever Acute Myeloid Leukemia Awareness Month in... May 25 2016
Sunesis Pharmaceuticals Announces Support of First-Ever Acute Myeloid Leukemia Awareness Month in... May 25 2016
ETF’s with exposure to Sunesis Pharmaceuticals, Inc. : May 19, 2016 May 19 2016
SUNESIS PHARMACEUTICALS INC Financials May 19 2016
Sunesis Pharmaceuticals Announces Oral Presentation on Vosaroxin at the 21st Congress of the... May 19 2016
Sunesis Pharmaceuticals Announces Oral Presentation on Vosaroxin at the 21st Congress of the... May 19 2016
Sunesis Pharmaceuticals, Inc. :SNSS-US: Earnings Analysis: Q1, 2016 By the Numbers May 18 2016
Sunesis to Present at the 2016 UBS Global Healthcare Conference May 18 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)